This test is certainly a welcome advance for quick testing at offices, schools, and just about any mass gathering place, which will stop the spread and save many lives. But we also need a quick results home test that would give everyone the ability to test themselves before leaving their homes, which would also save an untold number of lives, and would be a test not tied to a specific place such as work, doctors office, etc.
Executives from Moderna and Pfizer on Wednesday separately told the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice on Wednesday that mRNA-1273, which is Moderna’s coronavirus vaccine candidate, requires a storage temperature of negative 4 degrees Fahrenheit. BioNTech and Pfizer’s candidates, BN1162b2 and BNT162b2, need to be stored in negative 94 degrees Fahrenheit.
“These storage conditions would make traditional office or pharmacy administration very difficult,” SVB Leerink analysts wrote in a note to investors on Thursday.
A little-known biotech is working to surmount a hurdle that may hinder global access to a coronavirus vaccine.
Translate Bio Inc., a 100-person company based outside Boston, has joined forces with French drug giant Sanofi to develop a vaccine based on similar technology being used by Moderna Inc. in its highly anticipated shot. This so-called messenger RNA platform has been lauded as a possible solution for the coronavirus pandemic, but it comes with one significant drawback: The vaccine must be stored at minus-112 degrees Fahrenheit (minus-80 degrees Celsius).
Walk-in vault freezers for mass storage weren’t a practical option, Wheeler said. At -80 Celsius “you could probably survive for five seconds, even with a ski suit on. You’re better off building a farm with stand-up freezers that are mobile.”